Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Mimedx (MDXG) over the last 3 years, with Q3 2025 value amounting to $785000.0.

  • Mimedx's Interest & Investment Income rose 18237.41% to $785000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 18101.27%. This contributed to the annual value of -$1.0 million for FY2024, which is 8442.0% up from last year.
  • Mimedx's Interest & Investment Income amounted to $785000.0 in Q3 2025, which was up 18237.41% from $738000.0 recorded in Q2 2025.
  • In the past 5 years, Mimedx's Interest & Investment Income registered a high of $785000.0 during Q3 2025, and its lowest value of -$1.7 million during Q1 2024.
  • Its 3-year average for Interest & Investment Income is -$388000.0, with a median of $140500.0 in 2024.
  • As far as peak fluctuations go, Mimedx's Interest & Investment Income soared by 10018.4% in 2024, and later surged by 2450000.0% in 2025.
  • Mimedx's Interest & Investment Income (Quarter) stood at -$1.6 million in 2023, then soared by 125.3% to $403000.0 in 2024, then surged by 94.79% to $785000.0 in 2025.
  • Its Interest & Investment Income was $785000.0 in Q3 2025, compared to $738000.0 in Q2 2025 and $506000.0 in Q1 2025.